Oracle is making its Health Clinical AI Agent available to NHS trust and private practices. The note-taking software has been piloted at a number of hospital trusts in the UK, including Barts Health ...

Rising debts and questions surrounding its deal with OpenAI have led to investor concerns about the stock. Investors should not lose sight of its improving financials and increasingly attractive ...

Sam Altman, Jensen Huang, and Oracle have publicly said there's no tension. "We love working with NVIDIA," Altman wrote in a post on X. "I don't get where all this insanity is coming from." Their ...

The likelihood that Nvidia NVDA0.66%increase; green up pointing triangle will be investing far less than $100 billion in OpenAI raises big questions for Oracle ORCL-1.50%decrease; red down pointing ...

Colin is an Associate Editor focused on tech and financial news. He has more than three years of experience editing, proofreading, and fact-checking content on current financial events and politics.

Oracle’s remaining performance obligations surged to $523B. This represents roughly 8.5 times annual revenue. Oracle’s trailing free cash flow turned negative at $13B as capital expenditures soared ...

To finance its artificial-intelligence ambitions, Oracle is looking to raise more money at a time when Wall Street has gotten more worried about the level of financing underpinning the AI boom. The ...

Oracle and OpenAI have plans to build $500 billion of data centers in a venture called Stargate. JPMorgan Chase has seen slower investor interest for $38 billion of debt tied to two Stargate sites.

Michael Burry, the famed investor who has drawn attention in recent months for criticism of the artificial intelligence boom, is betting against Oracle Corp. Burry owns put options on Oracle shares, ...

Oracle (ORCL) has shown significant rallies in its history. In 2025, it experienced more than a 50% increase within two months. Moreover, there were seven occasions when ORCL appreciated over 30% in ...

Oracle Corporation (NYSE:ORCL) is one of the most active US stocks to buy according to analysts. On December 15, Phillip Securities lowered the firm’s price target on Oracle to $344 from $350 and ...